Biomed Central Ltd

SHERPA: Unknown

People

  1. Budhu
    Budhu
  2. Liu
    Liu
  3. Zhong
    Zhong
  4. Hirschhorn Cymerman
    Hirschhorn Cymerman
  5. Mangarin
    Mangarin
  6. Barker
    Barker
  7. Gupta
    Gupta
  8. Yang
    Yang
  9. Panageas
    Panageas
  10. Blasberg
    Blasberg

Groups

  1. Department of Medicine (22)
  2. Sloan Kettering Institute Postdocs (22)
  3. Solid Tumor Oncology Division (22)
  4. GSK Faculty (21)
  5. Melanoma and Immunotherapeutics Service (21)
  6. Hematology-Oncology Fellows (9)
  7. MSK Grad Students (7)
  8. Melanoma Disease Management Team (6)
  9. GME, Medicine (5)
  10. Graduate Medical Education (5)
Search Within
  1. "Sadna Budhu"
Formats
  1. Meeting Abstract (21)
  2. Journal Article (1)
Groups
  1. Department of Medicine (22)
  2. Sloan Kettering Institute Postdocs (22)
  3. Solid Tumor Oncology Division (22)
  4. GSK Faculty (21)
  5. Melanoma and Immunotherapeutics Service (21)
  6. Hematology-Oncology Fellows (9)

More Groups

People
  1. Sadna Budhu (22)
  2. Jedd Wolchok (21)
  3. Taha Merghoub (21)
  4. Roberta Zappasodi (12)
  5. Cailian Liu (8)
  6. Levi Mark Mangarin (7)

More People

Years
  1. 2022 (2)
  2. 2021 (4)
  3. 2020 (2)
  4. 2019 (1)
  5. 2018 (4)
  6. 2017 (4)

More Years

Publications
  1. Journal for ImmunoTherapy of Cancer (22)

Results (22)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Apr-246 induces an increase in tumor immunogenicity in a p53 independent manner
    Meeting Abstract

    Venkatesh, D.; Michels, J.; Lu, C.; Budhu, S.; George, M.; Ouerfelli, O.; Abrahmsen, L.; Zappasodi, R.; Wolchok, J.; Merghoub, T.
    Journal for ImmunoTherapy of Cancer (2022)

    Fulltext@MSK | Save
  • LDH inhibition improves response to CTLA-4 blockade by enhancing effector T cell activity and impairing regulatory T cell suppression
    Meeting Abstract

    Verma, S.; Serganova, I.; Budhu, S.; Dong, L.; Mangarin, L.; Ko, M.; Blasberg, R.; Zappasodi, R.; Wolchok, J.; Merghoub, T.
    Journal for ImmunoTherapy of Cancer (2022)

    Fulltext@MSK | Save
  • Combining a novel dual RAF/MEK inhibitor with immunomodulation to promote an anti-tumor response
    Meeting Abstract

    Dong, L.; Choi, H.; Budhu, S.; Schulze, I.; Mehanna, N.; Rosen, N.; Merghoub, T.; Wolchok, J.
    Journal for ImmunoTherapy of Cancer (2021)

    Fulltext@MSK | Save
  • Pharmacologic modulation of tumor glycolysis to improve responses to immune checkpoint blockade therapy
    Meeting Abstract

    Verma, S.; Maniyar, R.; Ko, M.; Budhu, S.; Serganova, I.; Zappasodi, R.; Blasberg, R.; Merghoub, T.; Wolchok, J.; Mangarin, L.
    Journal for ImmunoTherapy of Cancer (2021)

    Fulltext@MSK | Save
  • Isoform specific anti-TGFβ therapy enhances antitumor efficacy in mouse models of stroma poor cancers
    Meeting Abstract

    Budhu, S.; Gupta, A.; Fitzgerald, K.; Giese, R.; Michel, A.; Holland, A.; Campesato, L. F.; Van Snick, J.; Uyttenhove, C.; Ritter, G.; more...
    Journal for ImmunoTherapy of Cancer (2021)

    Fulltext@MSK | Save
  • T cell immunotherapies trigger neutrophil activation to eliminate tumor antigen escape variants
    Meeting Abstract

    Hirschhorn, D.; Budhu, S.; Schröder, D.; Kraehenbuehl, L.; Flammar, A. L.; Chow, A.; Schulze, I.; Schad, S.; Ricca, J.; Gasmi, B.; more...
    Journal for ImmunoTherapy of Cancer (2021)

    Fulltext@MSK | Save
  • Tim-4(+) resident macrophages impair anti-tumor immunity in the serous body cavities by sequestering viable and cytotoxic CD8(+) T cells expressing high levels of phosphatidylserine
    Meeting Abstract

    Chow, A.; Schad, S.; Green, M.; Hellmann, M.; Ceglia, N.; Allaj, V.; Zago, G.; Shah, N.; Sharma, S.; Mattar, M.; more...
    Journal for ImmunoTherapy of Cancer (2020)

    Fulltext@MSK | Save
  • Characterizing double positive T cells in the tumor microenvironment: A tale of promiscuous cell fates
    Meeting Abstract

    Schad, S.; Chow, A.; Pan, H.; Mangarin, L.; Zappasodi, R.; Gigoux, M.; Redmond, D.; Hirschhorn-Cymerman, D.; Budhu, S.; Zhong, H.; more...
    Journal for ImmunoTherapy of Cancer (2020)

    Fulltext@MSK | Save
  • Blockade of IDO/TDO downstream effectors restricts a Treg-macrophage suppressive axis and resistance to anti-PD-1 therapy
    Meeting Abstract

    Campesato, L.; Budhu, S.; Tchaicha, J.; Gigoux, M.; Cohen, I.; Mangarin, L.; Redmond, D.; Pourpe, S.; Liu, C.; Zappasodi, R.; more...
    Journal for ImmunoTherapy of Cancer (2019)

    Fulltext@MSK | Save
  • T cell immunotherapies trigger innate immunity and aseptic inflammation leading to potent anti-tumor and off-targets effects
    Meeting Abstract

    Hirschhorn-Cymerman, D.; Ricca, J.; Gasmi, B.; De Henau, O.; Mangarin, L.; Budhu, S.; Li, Y.; Cortez, C.; Liu, C.; Zappasodi, R.; more...
    Journal for ImmunoTherapy of Cancer (2018)

    Fulltext@MSK | Save